Skip to main content
OpenTrials

Clinical trial condition

Nervous System Neoplasms

Explore clinical trials studying Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

2,891 public trials 687 recruiting studies
Refine in advanced search Browse all conditions

Nervous System Neoplasms trial results

Completed

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

NCT02768389

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • University of Cincinnati Cincinnati, Ohio, United States
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive cancer Center Cleveland, Ohio, United States
  • OhioHealth Research and Innovation Institute Columbus, Ohio, United States
View Trial Details
Completed

SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

NCT01661283

Conditions
Fibrosarcoma, MPNST, Malignant Peripheral Nerve Sheath Tumors, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann and Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

NCT00404248

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

NCT02473952

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States
  • University of California-Irvine Orange, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Florida Health Science Center Jacksonville, Florida, United States
View all 40 locations
View Trial Details

Related conditions